Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous

PharmaTalkRadio

English - November 02, 2022 11:30 - 18 minutes - 16.3 MB - ★★★★ - 16 ratings
Science pharmaceutical biotech clinical trials patient engagement immuno-oncology drug delivery r&d Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: CMO-CEO Fireside Discussion on Working Through Challenges

Next Episode: Making Institutional Change to Offer Clinical Research Options in Health Systems

In this podcast, you will hear a presentation from Dr Robert Garmise, Bristol-Myers Squibb, and Dr Paul Reichert, Merck, from the 2022 PODD Conference regarding developing molecules in space to benefit subcutaneous drug delivery including case studies of work done in the International Space Station, the potential of crystalline suspensions and future opportunities.

To learn more about the PODD Conference, please visit PODDConference.com.